Breakthroughs in artificial intelligence are enhancing diagnostics and clinical data interpretation. Ultromics reported improved early detection of cardiac amyloidosis through FDA-cleared AI analysis of echocardiograms. Separately, InfEHR uses deep geometric learning to advance electronic health record phenotyping, enabling precision medicine. These technologies demonstrate AI's growing impact on diagnostic accuracy and healthcare delivery efficiency.